Ronald Sobecks is an Oncology physician affiliated with Cleveland Clinic. OpenAlex indexes 569 publications with 6,567 citations (h-index 40); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9500 Euclid Ave
Cleveland, OH 441950001
Telephone
800-223-2273Registry record last updated 7 Feb 2008.
Clinical trials
- Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation
Sponsor: Case Comprehensive Cancer Center
- Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
Sponsor: Case Comprehensive Cancer Center
- Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma
Sponsor: The Cleveland Clinic
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
28.4%Kinase inhibitor19.3%Jakafi100%Part D≥18 patientsSelective immunosuppressants4.6%Rezurock100%Part D<11 patients+ 2 more classes in this area
Dermatology
22.2%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor16.1%Acyclovir100%Part D≥31 patientsAzole Antifungal3.2%Clotrimazole100%Part D≥12 patients+ 1 more class in this area
Metabolism & gastrointestinal
15.7%Proton pump inhibitor8.7%Pantoprazole Sodium66%Omeprazole34%Part D<11 patientsPotassium supplement3.4%Potassium Chloride100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>
Journal of Clinical Oncology
2024 - Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation
Nature Communications
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Samir Kapadia, MD
Cleveland Clinic
Lars Svensson, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Gene Barnett, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”